Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012–2017) Based on Evolving National Policies in Rural Mozambique
Arinze F, Gong W, Green A, De Schacht C, Carlucci J, Silva W, Claquin G, Tique J, Stefanutto M, Graves E, Van Rompaey S, Alvim M, Tomo S, Moon T, Wester C. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012–2017) Based on Evolving National Policies in Rural Mozambique. AIDS Research And Human Retroviruses 2019, 36: 39-47. PMID: 31359762, PMCID: PMC9836686, DOI: 10.1089/aid.2019.0043.Peer-Reviewed Original ResearchConceptsCD4 cell countMedian CD4 cell countAntiretroviral therapyART initiationSevere immunodeficiencyCell countMedian changeHealth facilitiesHigher median CD4 cell countsMultivariable logistic regression modelAdvanced HIV diseaseAntiretroviral therapy (ART) startMedian CD4 cellProvider-initiated testingCombination antiretroviral therapyStage 4 diseaseTreatment-naive adultsLogistic regression modelsUniversal HIVOlder patientsCD4 cellsHIV diseaseTherapy startMale sexFemale sex